Citation Impact
Citing Papers
International consensus guidance for management of myasthenia gravis
2016 Standout
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
2014 Standout
Bronchoalveolar Lavage Galactomannan in Diagnosis of Invasive Pulmonary Aspergillosis among Solid-Organ Transplant Recipients
2007
The Chemokine Receptor CXCR3 Attenuates the Control of Chronic Mycobacterium tuberculosis Infection in BALB/c Mice
2007
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
2018 Standout
The use of sildenafil to treat portopulmonary hypertension prior to liver transplantation
2009
Drug Treatment of Pulmonary Arterial Hypertension
2005
Myasthenia Gravis
2016 Standout
MRI of the diabetic foot: differentiation of infection from neuropathic change
2007
Matrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral Therapy
2015 StandoutNobel
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
2006 Standout
PIM2 Induced COX-2 and MMP-9 Expression in Macrophages Requires PI3K and Notch1 Signaling
2009
Pulmonary hypertension in sarcoidosis: A review
2010
Matrix metalloproteinases in destructive pulmonary pathology
2005
Cancer drug resistance: an evolving paradigm
2013 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Successful Liver Transplantation Following Medical Management of Portopulmonary Hypertension: A Single-Center Series
2006
The pathogenesis of cardiac fibrosis
2013 Standout
Elevated Levels of Oxidative Stress Markers in Exhaled Breath Condensate
2009
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Sildenafil treatment for portopulmonary hypertension
2006
Lessons from phase III clinical trials on anti-VEGF therapy for cancer
2006
The Inflammation–Fibrosis Link? A Jekyll and Hyde Role for Blood Cells during Wound Repair
2007
Sarcoidosis
2013 Standout
Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?
2004 Standout
VEGF receptor signalling ? in control of vascular function
2006 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension
2006
Quantum imaging with undetected photons
2014 StandoutNatureNobel
Death receptors in chemotherapy and cancer
2004
Experience with inhaled iloprost and bosentan in portopulmonary hypertension
2007
Angiogenesis in life, disease and medicine
2005 StandoutNature
Physical Activity Is the Strongest Predictor of All-Cause Mortality in Patients With COPD
2011
Fluorescent Nanorods and Nanospheres for Real‐Time In Vivo Probing of Nanoparticle Shape‐Dependent Tumor Penetration
2011 StandoutNobel
Malignant Gliomas in Adults
2008 Standout
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer
2009
Acute and long-term effects of inhaled iloprost in portopulmonary hypertension
2010
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer-mediated malignant pleural effusion
2013
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Efficacy, safety and pharmacokinetics of bosentan in portopulmonary hypertension
2012
Pulmonary Microcirculation in Interstitial Lung Disease
2011
Safety and Efficacy of Ambrisentan for the Treatment of Portopulmonary Hypertension
2010
Bosentan for chronic thromboembolic pulmonary hypertension: Findings from a systematic review and meta-analysis
2010
Portopulmonary Hypertension
2008
Volatile biomarkers of pulmonary tuberculosis in the breath
2006
Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension
2007
Cyclopropane Modification of Trehalose Dimycolate Drives Granuloma Angiogenesis and Mycobacterial Growth through Vegf Signaling
2018 StandoutNobel
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Requirements for high impact diagnostics in the developing world
2006 StandoutNature
Deleterious Effects of β-Blockers on Exercise Capacity and Hemodynamics in Patients With Portopulmonary Hypertension
2006
Idiopathic pulmonary fibrosis
2011 Standout
Guidelines for treatment of autoimmune neuromuscular transmission disorders
2010
Induced Sputum MMP-1, -3 & -8 Concentrations during Treatment of Tuberculosis
2013
The increase in pulmonary arterial pressure caused by hypoxia depends on iron status
2008 StandoutNobel
Pulmonary hypertension complicating sarcoidosis
2012
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer
2009 Standout
ReviewBiomarkers in Breath Condensate: A promising New Non-invasive Technique in Free Radical Research
2003
Tumor Angiogenesis
2008 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Efficiency and safety of bosentan in child C cirrhosis with portopulmonary hypertension and renal insufficiency
2006
A Perivascular Niche for Brain Tumor Stem Cells
2007 Standout
Myasthenia gravis: subgroup classification and therapeutic strategies
2015 Standout
Matrix metalloproteinases in tuberculosis
2011
Endothelin-1 and Transforming Growth Factor-β1 Independently Induce Fibroblast Resistance to Apoptosis via AKT Activation
2009
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Pulmonary rehabilitation for chronic obstructive pulmonary disease
2015 Standout
The Role of Interleukin 17 in Tumour Proliferation, Angiogenesis, and Metastasis
2014
Lung Injury on Antiretroviral Therapy in Adults With Human Immunodeficiency Virus/Tuberculosis
2019 StandoutNobel
Sarcoidosis-Associated Pulmonary Hypertension
2017
Pulmonary Arterial Hypertension
2006
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Activation of the Interleukin-6/STAT3 Antiapoptotic Pathway in Esophageal Cells by Bile Acids and Low pH: Relevance to Barrett's Esophagus
2007
Potential and Challenges for Mid-Infrared Sensors in Breath Diagnostics
2009
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
The Immune Response in Tuberculosis
2013 Standout
Laboratory Diagnosis of Invasive Aspergillosis: From Diagnosis to Prediction of Outcome
2013
Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi
2015 Standout
Mycobacterial Trehalose Dimycolate Reprograms Macrophage Global Gene Expression and Activates Matrix Metalloproteinases
2012
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
2019 StandoutNobel
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Intraperitoneal VEGF Inhibition Using Bevacizumab: A Potential Approach for the Symptomatic Treatment of Malignant Ascites?
2009
Hidden Killers: Human Fungal Infections
2012 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Cell-Mediated Immune Responses in Tuberculosis
2009 Standout
Works of J. Schauer being referenced
Differential diagnosis of pleural effusions by fuzzy-logic-based analysis of cytokines
2003
BAX and p16INK4Aare independent positive prognostic markers for advanced tumour stage of nonsmall cell lung cancer
2002
Exhaled breath condensate acidification in acute lung injury
2003
Aspergillus detection in bronchoscopically acquired material. Significance and interpretation
2001
Unerwartete Ursache einer Fußwurzeldestruktion bei einem Diabetiker
2004
Bosentan Improves Exercise Tolerance and Tei Index in Patients With Pulmonary Hypertension and Prostanoid Therapy
2005
Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis
2001
The effect of respiratory muscle endurance training in patients with myasthenia gravis
2007
Vascular endothelial growth factor in pleural effusions of different origin
2005
Bosentan therapy for portopulmonary hypertension
2005
Different Expression of Endothelin in the Bronchoalveolar Lavage in Patients with Pulmonary Diseases
2001
Proinflammatory Cytokine Levels in Patients with Lung Cancer and Carcinomatous Pleurisy
1998
Factors influencing breath condensate volume
2001